HER2 Support Group Forums - View Single Post - FDA approves new therapy for adult patients with relapsing and primary progressive MS

News · 03-29-2017, 06:53 AM

On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS).

More...

03-29-2017, 06:53 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 19,747	FDA approves new therapy for adult patients with relapsing and primary progressive MS On March 28, the U.S. Food and Drug Administration approved Ocrevus (ocrelizumab) to treat adult patients with relapsing forms of multiple sclerosis (MS) and primary progressive multiple sclerosis (PPMS). More...